EUVIMEDEUVIMED entdecken
EditorialOpen Access

Property-based optimisation of PROTACs

James S Scott iD, Iacovos N Michaelides iD, Markus Schade iD

RSC Medicinal Chemistry · 2025 · 16 (2) · 449-456

DOI: 10.1039/d4md00769g ↗

Kurz gefasst

Editorial in der Zeitschrift RSC Medicinal Chemistry, 2025. Verfasst von James S Scott und 2 weiteren Autor:innen. Beteiligte Einrichtung: Oncology R&D, AstraZeneca 1 Francis Crick Avenue Cambridge CB2 0AA UK jamie.scott@astrazeneca.com. Die Arbeit wurde bisher 36-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PROTACs are an emerging therapeutic approach towards targeted protein degradation. This article examines the leading examples of this modality that are in clinical development through the prism of their physicochemical properties.

Autor:innen und Institutionen

  • Oncology R&D, AstraZeneca 1 Francis Crick Avenue Cambridge CB2 0AA UK jamie.scott@astrazeneca.com.
  • Discovery Sciences, AstraZeneca 1 Francis Crick Avenue Cambridge CB2 0AA UK.

ORCID-Profile: James S Scott, Iacovos N Michaelides, Markus Schade

Zitieren

APA

Scott, J. S., Michaelides, I. N., & Schade, M. (2025). Property-based optimisation of PROTACs. RSC Medicinal Chemistry, 16(2), 449-456. https://doi.org/10.1039/d4md00769g

Vancouver

Scott JS, Michaelides IN, Schade M. Property-based optimisation of PROTACs. RSC Medicinal Chemistry. 2025;16(2):449-456. doi:10.1039/d4md00769g

BibTeX
@article{Scott2025,
  author = {Scott, James S and Michaelides, Iacovos N and Schade, Markus},
  title = {Property-based optimisation of PROTACs},
  journal = {RSC Medicinal Chemistry},
  year = {2025},
  volume = {16},
  number = {2},
  pages = {449--456},
  doi = {10.1039/d4md00769g}
}
Kostenlos starten →